Immunocore and MEPC have announced a 53,000 sq ft expansion at Milton Park in Oxfordshire.
MEPC will provide the drug developer with a purpose-built research laboratory and facilities. It has been based at Milton Park since
Thank you for reading EG
Want to read more? Enjoy a story a day for FREE for one month.